Analysts Are Bullish on Top Healthcare Stocks: Tarsus Pharmaceuticals (TARS), Option Care Health (OPCH)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Tarsus Pharmaceuticals (TARS – Research Report) and Option Care Health (OPCH – Research Report) with bullish sentiments.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Tarsus Pharmaceuticals (TARS)
Oppenheimer analyst Andreas Argyrides maintained a Buy rating on Tarsus Pharmaceuticals on February 23 and set a price target of $105.00. The company’s shares closed last Tuesday at $75.01.
According to TipRanks.com, Argyrides is a 4-star analyst with an average return of
Tarsus Pharmaceuticals has an analyst consensus of Strong Buy, with a price target consensus of $91.57, implying a 22.8% upside from current levels. In a report released yesterday, TipRanks – DeepSeek also upgraded the stock to Buy with a $77.00 price target.
See today’s best-performing stocks on TipRanks >>
Option Care Health (OPCH)
In a report released today, David S Macdonald from Truist Financial reiterated a Buy rating on Option Care Health, with a price target of $40.00. The company’s shares closed last Tuesday at $33.82, close to its 52-week high of $35.53.
According to TipRanks.com, Macdonald is a 5-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Option Care Health with a $38.88 average price target, which is a 15.9% upside from current levels. In a report released today, Morgan Stanley also maintained a Buy rating on the stock with a $38.00 price target.
